Cello Health PLC Total Voting Rights (6659B)
June 10 2019 - 4:41AM
UK Regulatory
TIDMCLL
RNS Number : 6659B
Cello Health PLC
10 June 2019
10 June 2019
Cello Health plc
Total Voting Rights
As at 10 June 2019, Cello's issued share capital comprises
105,565,309 ordinary shares of 10 pence each ("Ordinary Shares"),
of which 453,000 Ordinary Shares are held in treasury. The total
number of current voting rights in the Company is therefore
105,112,309 Ordinary Shares.
The above figure (105,112,309 Ordinary Shares) may be used by
shareholders as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or
a change in their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
Enquiries:
Cello Health plc 020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Group Finance
Director
Cenkos Securities plc 020 7397 8900
Mark Connelly
Harry Hargreaves
Buchanan
Mark Court 020 7466 5000
Jamie Hooper
Sophie Wills
About Cello Health plc
Cello Health plc is a global healthcare-focused advisory Group
comprised of a set of leading clinical, commercial advisory and
digital delivery capabilities. Cello Health plc currently services
24 of the top 25 pharmaceutical clients globally, as well as a wide
range of biotech, diagnostics, devices and other key non-healthcare
clients.
Cello Health plc enables clients to commercialise and
differentiate their assets and drive brand success in ever more
complex global markets. The business delivers its services through
nearly 1,000 highly skilled professionals, utilising latest
thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in
the UK, USA, and Asia, with hub offices in New York City,
Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit:
https://cellohealthplc.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRVBLBFKQFXBBV
(END) Dow Jones Newswires
June 10, 2019 04:41 ET (08:41 GMT)
Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024